Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UMPS | P11172 | 2/20 | 1.00 |
| ▸ | PYGL | P06737 | 5/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | EIF4E | P06730 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | TOP1 | P11387 | 1/20 | 0.37 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.37 |
| ▸ | THPO | P40225 | 1/20 | 0.37 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyrazofurin SCHEMBL21392925 | 1.00 | UMPS (1.00) | UMPSPYGLSMN1; SMN2ALDH1A1TSHR | |
| Pyrazofurin SCHEMBL11835057 | 1.00 | UMPS (1.00) | UMPSPYGLSMN1; SMN2ALDH1A1TSHR | |
| Pyrazofurin SCHEMBL11826269 | 1.00 | UMPS (1.00) | UMPSPYGLSMN1; SMN2ALDH1A1TSHR | |
| Pyrazofurin SCHEMBL27539623 | 1.00 | UMPS (1.00) | UMPSPYGLSMN1; SMN2ALDH1A1TSHR | |
| Pyrazofurin SCHEMBL11835064 | 1.00 | UMPS (1.00) | UMPSPYGLSMN1; SMN2ALDH1A1TSHR | |
| Pyrazofurin SCHEMBL4860 | 1.00 | UMPS (1.00) | UMPSPYGLSMN1; SMN2ALDH1A1TSHR | |
| Pyrazofurin SCHEMBL29370114 | 1.00 | UMPS (1.00) | UMPSPYGLSMN1; SMN2ALDH1A1TSHR | |
| Pyrazofurin SCHEMBL11726623 | 0.99 | UMPS (0.97) | UMPSPYGLSMN1; SMN2ALDH1A1TSHR | |
| Pyrazofurin SCHEMBL10584948 | 0.95 | UMPS (0.90) | UMPSPYGLSMN1; SMN2ALDH1A1TSHR | |
| SCHEMBL11826483 | 0.78 | UMPS (0.63) | UMPSALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 11338 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144879-A1 | ANTI-VIRAL AND HEPATIC-TARGETED DRUGS | AI-BIOPHARMA (FR) | 2026-05-28 | — | — | US | claimed |
| US-20260116861-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| EP-4705284-A1 | 4'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO | Emory University (US) | 2026-03-11 | — | — | EP | claimed |
| US-12522572-B2 | Isoxazole hydroxamic acids as histone deacetylase 6 inhibitors | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-01-13 | — | — | US | claimed |
| WO-2025235664-A1 | PURINE NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO | EMORY UNIVERSITY (US) | 2025-11-13 | — | — | WO | claimed |
| US-20250268993-A1 | ALKALINE PHOSPHATE-BASED ONCOLOGY TREATMENTS | THERIVA BIOLOGICS, INC. | 2025-08-28 | — | — | US | claimed |
| US-12318434-B2 | Alkaline phosphate-based oncology treatments | THERIVA BIOLOGICS, INC. (US) | 2025-06-03 | — | — | US | claimed |
| US-12268694-B2 | Combination pharmaceutical agents as RSV inhibitors | ENANTA PHARMACEUTICALS, INC. (US) | 2025-04-08 | — | — | US | claimed |
| EP-4524131-A1 | SMALL MOLECULES FOR TREATING CANCER, INHABITING CHEMOKINE ACTIVITY AND/OR INDUCING CELL DEATH | AlonBio Ltd. (IL) | 2025-03-19 | — | — | EP | claimed |
| US-12202803-B2 | Small molecules for treating cancer, inhibiting chemokine activity and/or inducing cell death | ALONBIO LTD. (IL) | 2025-01-21 | — | — | US | claimed |
| EP-0594667-A4 | TREATMENT OF CHEMOTHERAPEUTIC AGENT AND ANTIVIRAL AGENT TOXICITY WITH ACYLATED PYRIMIDINE NUCLEOSIDES | PRO NEURON INC (US) | 1996-01-10 | — | — | EP | claimed |
| WO-1994026761-A1 | TREATMENT OF CHEMOTHERAPEUTIC AGENT AND ANTIVIRAL AGENT TOXICITY WITH ACYLATED PYRIMIDINE NUCLEOSIDES | PRO-NEURON, INC. (US) | 1994-11-24 | — | — | WO | claimed |
| EP-0594667-A1 | TREATMENT OF CHEMOTHERAPEUTIC AGENT AND ANTIVIRAL AGENT TOXICITY WITH ACYLATED PYRIMIDINE NUCLEOSIDES | PRO-NEURON, INC. (US) | 1994-05-04 | — | — | EP | claimed |
| CN-1071577-A | Handle the toxicity of chemotherapy reagent and Anti-virus agent with acylated pyrimidine nucleosides | PRO NEURON INC (US) | 1993-05-05 | — | — | CN | claimed |
| WO-1993001202-A1 | TREATMENT OF CHEMOTHERAPEUTIC AGENT AND ANTIVIRAL AGENT TOXICITY WITH ACYLATED PYRIMIDINE NUCLEOSIDES | PRO-NEURON, INC. (US) | 1993-01-21 | — | — | WO | claimed |
| EP-0500586-A4 | PYRIMIDINE BIOSYNTHESIS INHIBITORS USEFUL AS IMMUNOSUPPRESSIVE AGENTS | — | 1992-11-04 | — | — | EP | claimed |
| EP-0500586-A1 | PYRIMIDINE BIOSYNTHESIS INHIBITORS USEFUL AS IMMUNOSUPPRESSIVE AGENTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-09-02 | — | — | EP | claimed |
| US-5102883-A | Treating autoimmune diseases, antiinflammatory agent and organ transplantation rejection | DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1992-04-07 | — | — | US | claimed |
| WO-1991006863-A1 | PYRIMIDINE BIOSYNTHESIS INHIBITORS USEFUL AS IMMUNOSUPPRESSIVE AGENTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-05-16 | — | — | WO | claimed |
| US-4053698-A | ACYLATION OF PYRAZOFURIN | ELI LILLY AND COMPANY (US) | 1977-10-11 | — | — | US | claimed |